Boehringer’s Novel Exercise Claims In COPD May Spur FDA Action To Clarify Requirements

Company was hoping for an exercise tolerability claim for olodaterol, but members of the Pulmonary-Allergy Drugs Advisory Committee questioned several aspects of the trials and suggested FDA issue guidance on the matter.